Tvardi Therapeutics Q2 EPS $(1.00) Misses $(0.58) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $(0.58) by 73.01 percent.
Tvardi Therapeutics (NASDAQ:TVRD) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $(0.58) by 73.01 percent.